Lotus Eye Hospital and Institute Limited (LOTUSEYE.NS) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-124.4%

-₹26.40

vs ₹108.00 price

Levered DCF

-₹49.64

After debt service

Piotroski score

5 / 9

Average

Altman Z-score

—

Rating

C-

Overall 1 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
P/E	2,455.5×	197.29×	41.68×	29.9×	36.81×	54.67×	44.9×	66.03×
P/B	3.28×	2.43×	2.04×	2.12×	2.02×	1.62×	0.93×	0.93×
P/S	3.68×	2.94×	2.52×	2.59×	2.83×	2.63×	1.19×	1.23×
EV / EBITDA	46.42×	31.03×	15.1×	13.51×	15.81×	18.05×	10.95×	11.64×
Gross margin	19.0%	20.3%	28.1%	25.8%	49.5%	26.5%	52.6%	52.1%
Operating margin	-0.7%	0.9%	20.9%	10.1%	8.9%	4.1%	4.0%	1.2%
Net margin	0.1%	1.5%	6.0%	8.7%	7.7%	4.8%	2.7%	1.9%
Current ratio	1.22×	1.56×	2.25×	2.83×	2.23×	2.34×	1.79×	1.17×
Debt / equity	0.26×	0.06×	0.02×	0.02×	0.02×	0.01×	0.01×	0.01×
Interest coverage	-0.43×	1.2×	50.05×	23.3×	16.17×	9.6×	6.82×	2.17×
Dividend yield	0.0%	0.0%	0.9%	0.9%	0.9%	0.0%	0.0%	2.2%
Payout ratio	14.6%	1.4%	35.7%	25.5%	34.6%	0.0%	0.0%	147.1%

Key metrics by fiscal year

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Return on equity	0.1%	1.2%	4.9%	7.1%	5.5%	3.0%	2.1%	1.4%
Return on invested capital	0.7%	0.4%	12.0%	5.8%	4.5%	1.9%	2.3%	0.9%
Return on assets	0.1%	1.1%	4.4%	6.5%	4.8%	2.6%	1.8%	1.3%
Free cash flow yield	-5.4%	-1.5%	0.0%	1.1%	-0.2%	2.6%	5.4%	-1.1%
Earnings yield	0.0%	0.5%	2.4%	3.3%	2.7%	1.8%	2.2%	1.5%
Enterprise value	₹2.1B	₹1.5B	₹1.2B	₹1.2B	₹1.1B	₹804.8M	₹438.7M	₹454.2M
Net debt / EBITDA	3.08×	0.3×	-0.19×	-0.28×	-0.37×	-1.07×	-0.94×	-0.34×
Cash conversion cycle (days)	13	14	8	14	4	-0	-0	17